TRINETRA › Sectors › Chemicals
Astec LifeSciences Limited (ASTEC) — share price, P/E and fundamentals
Astec LifeSciences Limited (NSE: ASTEC) closed at ₹545.55 on 30 Oct 2026, -25.2% over one year, against a 52-week range of ₹513.40 – ₹941.75.
In the quarter ended 30 Sept 2026 (consolidated, filed 26 Oct 2026) it reported revenue of ₹72 cr and a net loss of ₹37 cr, a -51.9% net margin; revenue fell 2.3% year on year.
No trailing P/E is published: trailing twelve-month earnings are negative (-80 cr), so a P/E has no meaning — a loss-making business is not 'cheap' at a negative multiple. Judge it on revenue growth, cash burn and funding instead.
From the balance sheet dated 30 Sept 2026: return on equity -44.7%, ROCE -33.1%, debt-to-equity 0.99, Piotroski F-score 4 of 9.
Against 43 Chemicals peers on NSE: Net margin higher than 0% of 43 sector peers; PBT margin higher than 0% of 43 sector peers; ROE higher than 0% of 41 sector peers.
Key figures
| Last close | ₹545.55 (30 Oct 2026) |
|---|---|
| Change 1 month / 6 months / 1 year | -25.1% / -24.3% / -25.2% |
| 52-week low – high | ₹513.40 – ₹941.75 |
| Market capitalisation | ₹1,216 cr |
| Price / book | 3.63 |
| TTM EPS | ₹-35.71 |
| TTM net profit | ₹-80 cr |
| Quarter revenue | ₹72 cr |
| Quarter net loss | ₹37 cr |
| Net margin | -51.9% |
| Revenue growth (YoY) | -2.3% |
| Profit growth (YoY) | -53.3% |
| Return on equity | -44.7% |
| ROCE | -33.1% |
| Debt / equity | 0.99 |
| Current ratio | 0.74 |
| Free cash flow | ₹120 cr |
| Piotroski F-score | 4 / 9 |
| Average daily turnover (50 days) | ₹2.5 cr |
Against Chemicals peers
| Metric | ASTEC | Peer median | Percentile |
|---|---|---|---|
| Net margin | -51.94 | 9.91 | 0 |
| PBT margin | -51.97 | 13.29 | 0 |
| ROE | -44.70 | 13.64 | 0 |
| ROCE | -33.12 | 16.08 | 0 |
| Debt / equity | 0.99 | 0.23 | 85 |
| FCF margin | 77.21 | 0.76 | 100 |
| P/B | 3.63 | 3.84 | 50 |
Questions
What were Astec LifeSciences Limited's latest quarterly results?
For the quarter ended 30 Sept 2026, Astec LifeSciences Limited reported revenue of ₹72 cr and a net loss of ₹37 cr (consolidated), filed with the exchange on 26 Oct 2026.
What is Astec LifeSciences Limited's ROE?
Return on equity is -44.7% based on the balance sheet dated 30 Sept 2026.
Does Astec LifeSciences Limited have debt?
Debt-to-equity is 0.99 on the balance sheet dated 30 Sept 2026.
What is ASTEC's 52-week high and low?
Over the last 52 weeks to 30 Oct 2026, ASTEC traded between ₹513.40 and ₹941.75.
Other Chemicals stocks
- Solar Industries India Limited (SOLARINDS)
- Pidilite Industries Limited (PIDILITIND)
- SRF Limited (SRF)
- Coromandel International Limited (COROMANDEL)
- Linde India Limited (LINDEINDIA)
- Gujarat Fluorochemicals Limited (FLUOROCHEM)
- Navin Fluorine International Limited (NAVINFLUOR)
- Fertilizers and Chemicals Travancore Limited (FACT)
- UPL Limited (UPL)
- Himadri Speciality Chemical Limited (HSCL)
- Aether Industries Limited (AETHER)
- Deepak Nitrite Limited (DEEPAKNTR)
Source: consolidated SEBI Integrated Filing for the quarter ended 30 Sept 2026 and NSE daily closes. Open the interactive terminal view for charts and the full statements.
TRINETRA is a research and education tool. Nothing on this site is investment advice or a recommendation to buy or sell any security. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing. Figures are as filed with NSE/SEBI and as of the dates shown; they are not live prices.